Search results
U.S. Military Laser Weapon Programs Are Facing A Reality Check
THE WARZONE via Yahoo News· 5 days agoThere were other non-laser-related questions about how such a capability would be employed and MDA...
Biz Bytes
Quad-City Times· 15 hours agoThe YWCA Quad Cities will host a ribbon cutting to celebrate their new facility on Monday, June 3 at 1:00 pm. They are located at 513 17th Street in Rock Island, IL. The new YWCA QC building ...
ROK Resources Files Financial Results and Management Discussion & Analysis for the First Quarter of...
Digital Journal· 5 days agoREGINA, SK / ACCESSWIRE / May 21, 2024 / ROK Resources Inc. ("ROK" or the "Company") (TSXV:ROK)(OTCQB:ROKRF) has filed its interim Financial Results and Management Discussion ...
Biz Bytes
Quad-City Times· 15 hours agoAscentra Credit Union and the Ascentra Credit Union Foundation have established a $60,000 grant, dispersed over three years, for Humility Homes & Services, Inc. (HHSI) to assist in achieving housing
A man who lost 40 pounds — and cut 10 inches from his waistline — recommends walking, protein swaps,...
INSIDER via Yahoo News· 13 hours agoDiabetes medications including Ozempic weren't working for this CEO. So he started a "digital twin" ...
State of Freight webinar for May: Not an inflection point yet but a benchmark turns higher
FreightWaves· 3 days agoIt isn’t much but a recent upward turn in the Outbound Tender Rejection Index in FreightWaves SONAR...
Ozempic users will soon get their own heat-and-eat meals
Business Insider· 5 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Endava (NYSE:DAVA) PT Lowered to $50.00
ETF DAILY NEWS· 2 days agoEndava (NYSE:DAVA – Get Free Report) had its price target cut by Wedbush from $65.00 to $50.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently ...
Ginkgo Bioworks (NYSE:DNA) Sees Strong Trading Volume
ETF DAILY NEWS· 2 days agoTD Cowen lowered their target price on shares of Ginkgo Bioworks from $7.00 to $3.00 and set an “outperform” rating for the company in a research note on Friday, March 1st. Morgan Stanley lowered ...
Ozempic cuts risk of death from kidney disease, major study finds
Anchorage Daily News· 2 days agoThe active compound in the best-selling drug Ozempic markedly lowers the risk of complications from...
